Unity Biotechnology, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.74 | $157.41 M | -2.5 | 51 | $0 |
AVIR
Atea Pharmaceuticals, Inc. |
$3.10 | $311.63 M | -1.9 | 75 | $0 |
BEAM
Beam Therapeutics Inc. |
$26.28 | $1.91 B | -14.51 | 472 | $377.71 M |
BXRX
Baudax Bio, Inc. |
$0.02 | $950,330 | -0 | 9 | $1.27 M |
CNTB
Connect Biopharma Holdings Limited |
$1.07 | $108.00 M | -1.81 | 81 | $0 |
DRMA
Dermata Therapeutics, Inc. |
$1.17 | $1.47 M | -0.25 | 8 | $0 |
EDIT
Editas Medicine, Inc. |
$1.41 | $435.86 M | -2.56 | 265 | $78.12 M |
ENSC
Ensysce Biosciences, Inc. |
$7.86 | $4.14 M | -0.17 | 7 | $2.23 M |
EXAI
Exscientia plc |
$4.84 | $679.46 M | -4.05 | 483 | $20.08 M |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
HOOK
HOOKIPA Pharma Inc. |
$2.06 | $79.07 M | -1.71 | 151 | $20.13 M |
HRTX
Heron Therapeutics, Inc. |
$1.76 | $542.35 M | -6.55 | 126 | $127.04 M |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
NTLA
Intellia Therapeutics, Inc. |
$11.26 | $2.19 B | -4.23 | 526 | $36.28 M |
NUVB
Nuvation Bio Inc. |
$2.77 | $684.66 M | -8.66 | 203 | $0 |
NXTC
NextCure, Inc. |
$0.84 | $38.88 M | -0.61 | 82 | $0 |
OVID
Ovid Therapeutics Inc. |
$0.71 | $210.00 M | -4.11 | 25 | $391,695 |
PBLA
Panbela Therapeutics, Inc. |
$0.40 | $1.80 M | 0.01 | 7 | $0 |
PRME
Prime Medicine, Inc. |
$3.26 | $788.60 M | -3.01 | 234 | $0 |
RNA
Avidity Biosciences, Inc. |
$30.09 | $2.54 B | -8.99 | 253 | $9.56 M |
RXRX
Recursion Pharmaceuticals, Inc. |
$7.51 | $1.96 B | -5.22 | 500 | $44.58 M |
VERV
Verve Therapeutics, Inc. |
$8.00 | $409.24 M | -1.82 | 255 | $11.76 M |
WINT
Windtree Therapeutics, Inc. |
$0.20 | $1.88 M | 0.24 | 20 | $0 |